Data from the ORBITA-2 randomized, placebo-controlled trial emphasize that patient age alone should not be the deciding ...

In-hospital mortality was significantly lower in patients aged 90 years or older treated with PCI compared with medical management.

Abbreviated dual antiplatelet therapy after percutaneous coronary intervention using third-generation stents remained noninferior vs. 12-month DAPT for non-ST-segment elevation myocardial infarction ...

Researchers made a case for failure to rescue (FTR) as a potential quality metric in percutaneous coronary intervention (PCI), using records from a large nationwide registry. Although PCI is ...

Please provide your email address to receive an email when new articles are posted on . For patients with vulnerable plaque but no flow-limiting stenosis, PCI provided better clinical outcomes than ...

Operators safely shaved a few minutes off heart attack reperfusion times by taking patients straight to culprit lesion percutaneous coronary intervention (PCI) when they arrived at the catheterization ...

People with a buildup of fatty atherosclerotic plaque in the heart's arteries considered at risk of rupturing were far less likely to suffer a serious cardiac event if they underwent percutaneous ...

Percutaneous coronary intervention volumes fell by 55 percent in the early months of the pandemic, a survey of 360 cardiac catheterization laboratories shows. The survey was administered by ...

Long-term MACE and mortality rates are comparable between patients with and without diabetes following IVL-assisted percutaneous coronary intervention.

A three-day cardiac conclave hosted by Meril Life Sciences in Vapi from January 16th–18th VAPI, India, Jan ...

At PRISM-PCI Conclave 2026, global cardiology experts discuss how precision-driven innovation is transforming angioplasty and ...